3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
108
Leukemia, Lymphocytic, Chronic, B-Cell
30
Myelodysplastic Syndromes
23
Leukemia, Biphenotypic, Acute
11
Recurrence
10
Lymphoma, Mantle-Cell
9
Leukemia
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Myelomonocytic, Chronic
8
Burkitt Lymphoma
8
Waldenstrom Macroglobulinemia
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, B-Cell, Marginal Zone
7
Lymphoma
7
Hematologic Neoplasms
7
Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
6
Myeloproliferative Disorders
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Follicular
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Multiple Myeloma
3
Anemia, Refractory, with Excess of Blasts
3
Sarcoma, Myeloid
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, B-Cell
2
Leukemia, Myeloid
2
Immunoglobulin Light-chain Amyloidosis
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Blast Crisis
2
Interventions
Tretinoin
3
Arsenic Trioxide
3
arsenous acid
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Magnetic Resonance Spectroscopy
1
Lisaftoclax
1
Idarubicin
1
Gemtuzumab
1
Gadolinium
1
Fluorodeoxyglucose F18
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Promyelocytic, Acute
×
venetoclax
×
90 days
×
Clear all
No trials found.